Bank of America Corporation, through its finance subsidiary BofA Finance LLC, has announced the issuance of Medium-Term Notes, Series A, which are market-linked securities fully and unconditionally guaranteed by Bank of America Corporation. These securities are auto-callable with a fixed percentage buffered downside, linked to the lowest performing stock between Bristol-Myers Squibb Company and Pfizer Inc. The principal amount at risk is $3,295,000, with the securities due on April 29, 2027. The securities do not pay interest and do not guarantee a fixed principal repayment at maturity. Instead, the return depends on the performance of the underlying stocks, with potential automatic call based on the stock closing price of the lowest performing stock on predetermined call dates. The call...Show More

Bank of America Corporation, through its finance subsidiary BofA Finance LLC, has announced the issuance of Medium-Term Notes, Series A, which are market-linked securities fully and unconditionally guaranteed by Bank of America Corporation. These securities are auto-callable with a fixed percentage buffered downside, linked to the lowest performing stock between Bristol-Myers Squibb Company and Pfizer Inc. The principal amount at risk is $3,295,000, with the securities due on April 29, 2027. The securities do not pay interest and do not guarantee a fixed principal repayment at maturity. Instead, the return depends on the performance of the underlying stocks, with potential automatic call based on the stock closing price of the lowest performing stock on predetermined call dates. The call premium increases for each call date, with a maximum of 81.750% of the principal amount. If not called, the maturity payment amount could be equal to or less than the principal, depending on the final stock price of the lowest performing stock. Investors may lose up to 90% of the principal amount. The securities are not listed on any securities exchange and offer no periodic interest payments. The initial estimated value per security is $946.00, which is less than the public offering price of $1,000.00 per security. The offering includes a public offering price of $3,295,000.00, an underwriting discount of $84,846.25, and proceeds before expenses to BofA Finance of $3,210,153.75. Wells Fargo Securities, LLC and BofA Securities, Inc. are the selling agents. The issue date is set for May 1, 2024, with the pricing date on April 26, 2024.